| Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo SC Bodine, TN Stitt, M Gonzalez, WO Kline, GL Stover, R Bauerlein, ... Nature cell biology 3 (11), 1014-1019, 2001 | 3140 | 2001 |
| The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors TN Stitt, D Drujan, BA Clarke, F Panaro, Y Timofeyva, WO Kline, ... Molecular cell 14 (3), 395-403, 2004 | 2219 | 2004 |
| Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy KMV Lai, M Gonzalez, WT Poueymirou, WO Kline, E Na, E Zlotchenko, ... Molecular and cellular biology 24 (21), 9295-9304, 2004 | 516 | 2004 |
| The Matchmaker Exchange: a platform for rare disease gene discovery AA Philippakis, DR Azzariti, S Beltran, AJ Brookes, CA Brownstein, ... Human mutation 36 (10), 915-921, 2015 | 488 | 2015 |
| Association of prior antibiotic treatment with survival and response to immune checkpoint inhibitor therapy in patients with cancer DJ Pinato, S Howlett, D Ottaviani, H Urus, A Patel, T Mineo, C Brock, ... JAMA oncology 5 (12), 1774-1778, 2019 | 471 | 2019 |
| De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy S Syrbe, U Hedrich, E Riesch, T Djémié, S Müller, RS Møller, B Maher, ... Nature genetics 47 (4), 393-399, 2015 | 284 | 2015 |
| Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer MA Gonzalez, SE Pinder, G Callagy, SL Vowler, LS Morris, K Bird, JA Bell, ... Journal of clinical oncology 21 (23), 4306-4313, 2003 | 281 | 2003 |
| Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions M Gonzalez, FP Ruggiero, Q Chang, YJ Shi, MM Rich, S Kraner, ... Neuron 24 (3), 567-583, 1999 | 268 | 1999 |
| From genome to vaccine: in silico predictions, ex vivo verification AS De Groot, A Bosma, N Chinai, J Frost, BM Jesdale, MA Gonzalez, ... Vaccine 19 (31), 4385-4395, 2001 | 250 | 2001 |
| Cell‐cycle‐dependent regulation of DNA replication and its relevance to cancer pathology KK Tachibana, MA Gonzalez, N Coleman The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 233 | 2005 |
| PNPLA6 mutations cause Boucher-Neuhäuser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum M Synofzik, MA Gonzalez, CM Lourenco, M Coutelier, TB Haack, ... Brain 137 (1), 69-77, 2014 | 223 | 2014 |
| Gap junctional coupling and patterns of connexin expression among neonatal rat lumbar spinal motor neurons Q Chang, M Gonzalez, MJ Pinter, RJ Balice-Gordon Journal of Neuroscience 19 (24), 10813-10828, 1999 | 219 | 1999 |
| Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia C Tesson, M Nawara, MAM Salih, R Rossignol, MS Zaki, M Al Balwi, ... The American Journal of Human Genetics 91 (6), 1051-1064, 2012 | 214 | 2012 |
| Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder AJ Abrams, RB Hufnagel, A Rebelo, C Zanna, N Patel, MA Gonzalez, ... Nature genetics 47 (8), 926-932, 2015 | 208 | 2015 |
| Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia E Martin, R Schüle, K Smets, A Rastetter, A Boukhris, JL Loureiro, ... The American Journal of Human Genetics 92 (2), 238-244, 2013 | 197 | 2013 |
| Control of DNA replication and its potential clinical exploitation MA Gonzalez, KK Tachibana, RA Laskey, N Coleman Nature Reviews Cancer 5 (2), 135-141, 2005 | 193 | 2005 |
| Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia EC Oates, AM Rossor, M Hafezparast, M Gonzalez, F Speziani, ... The American Journal of Human Genetics 92 (6), 965-973, 2013 | 186 | 2013 |
| Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12 G Montenegro, AP Rebelo, J Connell, R Allison, C Babalini, M D’Aloia, ... The Journal of clinical investigation 122 (2), 538-544, 2012 | 185 | 2012 |
| Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2 AR Foley, MP Menezes, A Pandraud, MA Gonzalez, A Al-Odaib, ... Brain 137 (1), 44-56, 2014 | 183 | 2014 |
| Candida dubliniensis, a new fungal pathogen J Gutierrez, P Morales, MA Gonzalez, G Quindos Journal of Basic Microbiology: An International Journal on Biochemistry …, 2002 | 183 | 2002 |
